Empowering people affected by MS to live their best lives

Other Global Collaborations

International Progressive MS Alliance

We cofounded this global collaboration to end progressive MS.

MS Outcome Assessments Consortium (MSOAC)

We cocreated this effort to improve outcomes of MS trials.

International MS Genetics Consortium (IMSGC)

IMSGC completed the largest MS genetics study to date with Society funding.

International MS Microbiome Study (iMSMS)

Our seed funding launched this study on gut bacteria and MS.

International Advisory Committee on Clinical Trials in MS

We cosponsor this committee of global experts in MS trials and diagnosis.

Commercial Research Funding

Our unique funding program reduces the risk involved in developing new treatment strategies for MS.

Building the MS Workforce

We’ve recruited and provided training to more than 1,000 new MS researchers, all dedicated to MS cures.

Research Funding Opportunities

Review grants and fellowships for researchers as well as clinicians.

Research on Stem Cells and MS

Learn about stem cells and how they may be used to treat MS.

Participate in Research Studies

From participating in clinical trials to responding to surveys, you have a range of options should you decide to help.

Track Record of Progress

In 1946 the National MS Society sponsored its first 3 research projects. Today our investment in innovative research exceeds $1 billion. With this investment, we’ve:

Provided early career support and funding to many thought leaders in MS research
Set standards in diagnosis, symptom management, pediatric MS, integrative therapies, rehabilitation and wellness research, clinical trial strategies and stem cell research
Targeted highly promising areas of research — such as race and gender differences — to expedite progress and set the stage for clinical trials
Helped launch the MS field of nerve and myelin repair, which resulted in trials of repair strategies to restore function for people living with MS
Drove research uncovering genes that contribute to MS susceptibility and new treatment avenues, and funded pivotal findings on the role of EBV and other viral triggers of MS
Funded a groundbreaking study that produced a scientifically sound measure of the prevalence of MS to help us better understand the disease and find solutions
Paved the way for the development of disease-modifying therapies for MS

In 1946 the National MS Society sponsored its first 3 research projects. Today our investment in innovative research exceeds $1 billion. With this investment, we’ve:

Provided early career support and funding to many thought leaders in MS research
Set standards in diagnosis, symptom management, pediatric MS, integrative therapies, rehabilitation and wellness research, clinical trial strategies and stem cell research
Targeted highly promising areas of research — such as race and gender differences — to expedite progress and set the stage for clinical trials
Helped launch the MS field of nerve and myelin repair, which resulted in trials of repair strategies to restore function for people living with MS
Drove research uncovering genes that contribute to MS susceptibility and new treatment avenues, and funded pivotal findings on the role of EBV and other viral triggers of MS
Funded a groundbreaking study that produced a scientifically sound measure of the prevalence of MS to help us better understand the disease and find solutions
Paved the way for the development of disease-modifying therapies for MS

All MS Research

Displaying 4 of 195 results

Sort By

Research Funded by the National MS Society

Other Global Collaborations

More on MS Research

Track Record of Progress

All MS Research

National MS Society-Funded Study Points to Potential New Myelin Repair Strategy

New Study: Is It Time to Rethink How We Describe Multiple Sclerosis?

People with MS Twice as Likely to Experience Any Type of Headache, Says New, Small Study

National MS Society-Funded Study Identifies Genetic Marker That Predicts Response to MS Treatment